Literature DB >> 19805187

Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome.

Karen T Chang1, Kyung-Tai Min.   

Abstract

At the neuronal level of Down syndrome (DS) brains, there are evidences of altered shape, number, and density of synapses, as well as aberrant endocytosis associated with accumulation of enlarged endosomes, suggesting that proteins involved in synaptic vesicle recycling may play key roles in DS neurons. However, the exact mechanism underlying those anomalies is not well understood. We hypothesize that overexpression of three genes, dap160/itsn1, synj/synj1, and nla/dscr1, located on human chromosome 21 play important roles in DS neurons. Here, we systematically investigate the effects of multiple gene overexpression on synaptic morphology and endocytosis to identify possible dominant gene or genes. We found that overexpression of individual genes lead to abnormal synaptic morphology, but all three genes are necessary to cause impaired vesicle recycling and affect locomotor vigor. Furthermore, we report that dap160 overexpression alters the subcellular distribution of synaptojanin, and overexpression of nla regulates the phosphoinositol 5' phosphatase activity of synaptojanin. These findings imply that restoring the level of any one of these genes may reduce endocytic defects seen in DS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805187      PMCID: PMC2761307          DOI: 10.1073/pnas.0904397106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation.

Authors:  Karen T Chang; Yi-Jun Shi; Kyung-Tai Min
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

2.  Rapid Ca2+-dependent decrease of protein ubiquitination at synapses.

Authors:  Hong Chen; Simona Polo; Pier Paolo Di Fiore; Pietro V De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Predicting pathway perturbations in Down syndrome.

Authors:  K Gardiner
Journal:  J Neural Transm Suppl       Date:  2003

4.  Functional dissection of a eukaryotic dicistronic gene: transgenic stonedB, but not stonedA, restores normal synaptic properties to Drosophila stoned mutants.

Authors:  Patricia S Estes; Taryn C Jackson; Daniel T Stimson; Subhabrata Sanyal; Leonard E Kelly; Mani Ramaswami
Journal:  Genetics       Date:  2003-09       Impact factor: 4.562

5.  Dap160/intersectin scaffolds the periactive zone to achieve high-fidelity endocytosis and normal synaptic growth.

Authors:  Bruno Marie; Sean T Sweeney; Kira E Poskanzer; Jack Roos; Regis B Kelly; Graeme W Davis
Journal:  Neuron       Date:  2004-07-22       Impact factor: 17.173

6.  Dap160/intersectin acts as a stabilizing scaffold required for synaptic development and vesicle endocytosis.

Authors:  Tong-Wey Koh; Patrik Verstreken; Hugo J Bellen
Journal:  Neuron       Date:  2004-07-22       Impact factor: 17.173

7.  App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.

Authors:  Anne M Cataldo; Suzana Petanceska; Corrinne M Peterhoff; Nicole B Terio; Charles J Epstein; Angela Villar; Elaine J Carlson; Matthias Staufenbiel; Ralph A Nixon
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

8.  Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction.

Authors:  M Martínez de Lagrán; X Altafaj; X Gallego; E Martí; X Estivill; I Sahún; C Fillat; M Dierssen
Journal:  Neurobiol Dis       Date:  2004-02       Impact factor: 5.996

9.  Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses.

Authors:  Sang Yoon Lee; Markus R Wenk; Yong Kim; Angus C Nairn; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

10.  Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating.

Authors:  Patrik Verstreken; Tong-Wey Koh; Karen L Schulze; R Grace Zhai; P Robin Hiesinger; Yi Zhou; Sunil Q Mehta; Yu Cao; Jack Roos; Hugo J Bellen
Journal:  Neuron       Date:  2003-11-13       Impact factor: 17.173

View more
  38 in total

1.  A novel binding protein of single-minded 2: the mitotic arrest-deficient protein MAD2B.

Authors:  Xianfang Meng; Xiujuan Tian; Xiaolan Wang; Pan Gao; Chun Zhang
Journal:  Neurogenetics       Date:  2012-06-02       Impact factor: 2.660

2.  Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Jessica Gall; Lizzy George; Rachel Nosheny; Michael T Maloney; Ahmad Salehi; William C Mobley
Journal:  Neurobiol Dis       Date:  2011-10-17       Impact factor: 5.996

3.  Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation.

Authors:  Eun Hye Lee; Seon Sook Kim; Seul Lee; Kwan-Hyuck Baek; Su Ryeon Seo
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

Review 4.  Physiologic and anatomic characterization of the brain surface glia barrier of Drosophila.

Authors:  Michael K DeSalvo; Nasima Mayer; Fahima Mayer; Roland J Bainton
Journal:  Glia       Date:  2011-02-23       Impact factor: 7.452

5.  Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.

Authors:  Dan N Predescu; Cristina Bardita; Rajive Tandon; Sanda A Predescu
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

6.  Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease.

Authors:  Sarah B Martin; Amy L S Dowling; Joann Lianekhammy; Ira T Lott; Eric Doran; M Paul Murphy; Tina L Beckett; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 7.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

8.  Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease.

Authors:  Maria Vounou; Eva Janousova; Robin Wolz; Jason L Stein; Paul M Thompson; Daniel Rueckert; Giovanni Montana
Journal:  Neuroimage       Date:  2011-12-22       Impact factor: 6.556

9.  The Sac domain-containing phosphoinositide phosphatases: structure, function, and disease.

Authors:  FoSheng Hsu; Yuxin Mao
Journal:  Front Biol (Beijing)       Date:  2013-08

Review 10.  The role of phosphoinositides in synapse function.

Authors:  Yoshibumi Ueda
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.